| # | Drug | Count |
|---|---|---|
| 0 | ABACAVIR | 10 |
| 1 | ABACAVIR SULFATE | 10 |
| 2 | LAMIVUDINE | 10 |
| 3 | LAMIVUDINE ORAL | 10 |
| 4 | NEVIRAPINE | 10 |
| 5 | TENOFOVIR ALAFENAMIDE | 10 |
| 6 | ZIDOVUDINE | 10 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE | 8 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 8 |
| 9 | DARUNAVIR | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEVIRAPINE | 10 | 0.0011 |
| 1 | ABACAVIR SULFATE | 10 | 0.0010 |
| 2 | ZIDOVUDINE | 10 | 0.0010 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 8 | 0.0009 |
| 4 | DARUNAVIR 600 MG | 4 | 0.0006 |
| 5 | ENTRECTINIB | 1 | 0.0006 |
| 6 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 7 | LAMIVUDINE | 10 | 0.0004 |
| 8 | RITONAVIR 100 MG | 5 | 0.0003 |
| 9 | DARUNAVIR | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0004 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0002 |
| 2 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0001 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |